Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma.
about
Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinomaPrognostic significance of latent membrane protein 1 expression in non-Hodgkin lymphoma: A meta-analysis.EBV-encoded LMP1 upregulates Igκ 3'enhancer activity and Igκ expression in nasopharyngeal cancer cells by activating the Ets-1 through ERKs signaling.Human tumor virus utilizes exosomes for intercellular communication.DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomasTyrosylprotein sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4 are induced by Epstein-Barr virus encoded latent membrane protein 1 and associated with the metastatic potential of human nasopharyngeal carcinoma.Increased phosphorylation of histone H3 at serine 10 is involved in Epstein-Barr virus latent membrane protein-1-induced carcinogenesis of nasopharyngeal carcinoma.Prognostic significance of EBV latent membrane protein 1 expression in lymphomas: evidence from 15 studiesFluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up.Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy.A gender-specific association of CNV at 6p21.3 with NPC susceptibilityThe Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies.Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.Incidence of Epstein-Barr virus in Syrian women with breast cancer: A tissue microarray study.Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model.Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral ReplicationThe Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A/TGFβ and β1 integrin signalling.Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma.Role of leukemia inhibitory factor in nasopharyngeal carcinogenesis.Upregulation of special AT-rich-binding protein 1 by Epstein-Barr virus latent membrane protein 1 in human nasopharyngeal cells and nasopharyngeal cancer.Delivery system for DNAzymes using arginine-modified hydroxyapatite nanoparticles for therapeutic application in a nasopharyngeal carcinoma model.Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virus-triggered B cell proliferation.Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance.Epigenetic deregulation of the LMP1/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding site.Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas.Tumor-derived exosomes and microvesicles in head and neck cancer: implications for tumor biology and biomarker discovery.Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic?Signal transduction in cancerThe role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.Elimination of LMP1-expressing cells from a monolayer of gastric cancer AGS cellsImmunotherapy against cancer-related viruses.Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids.Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways.Viral oncoprotein LMP1 disrupts p53-induced cell cycle arrest and apoptosis through modulating K63-linked ubiquitination of p53.A novel LMP1 antibody synergizes with mitomycin C to inhibit nasopharyngeal carcinoma growth in vivo through inducing apoptosis and downregulating vascular endothelial growth factorInhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cells.Nasopharyngeal carcinoma with skull base erosion cytologic findings.Epstein-barr virus latent membrane protein 1 polymorphism in nasopharyngeal carcinoma and other oral cavity tumors in Russia.The protective role of polymorphism MKK4-1304 T>G in nasopharyngeal carcinoma is modulated by Epstein-Barr virus' infection status.
P2860
Q28087059-C25DF9F3-6D01-44E7-8A8A-A1889DFAFD1AQ33621277-6BE8AB14-F29B-4096-9FEC-068E665E2DDDQ34187244-5EE2C7F7-19BB-450A-9D27-EA8DE21A22CEQ34377767-37BFB21C-92EF-4FC2-A146-874148584A77Q34582022-436797EE-21A0-4DE9-BA18-C6948393ED31Q34614264-84628749-D478-4BD3-9AD6-3A18F38C41BEQ34621624-2D078811-74E9-4C27-B7D5-16EAB6392F24Q34683653-C7D100E8-485D-48D0-92D5-3DF1DBB62C2EQ34841962-74EFCD77-FEE5-4875-BDDB-32A78E5282A5Q35067738-BE2F29E6-FFEE-42B2-A00C-0D8ADF436945Q35067875-88AC9C17-BA42-46AD-9500-39D72CE63DD5Q35135041-D43EDE02-E85F-4B89-92FC-FF813C6F2D9DQ35495968-78C98D1F-9392-42B3-AD41-02C589C8A2D0Q35641151-2A98D0BC-D7E3-477A-8C3A-1391FE6EABCAQ35887107-09917039-46AD-4F7E-8822-031E9C48FFBEQ35943724-2E2A2470-05B9-4158-B242-5115968E4F1BQ36434290-21320C15-8C39-4D1A-B5BE-7B3460FEB8E3Q36500037-994A84DF-B91D-4256-91DC-2A282B04B984Q36613732-4EBB0740-6686-4779-B471-1D072F1D8E28Q36997722-2417B266-F157-43D4-B32C-AA98B0EF4BBBQ37006707-3CA506A3-636B-442C-B015-C6448F89D5F2Q37106316-8DE8D08A-D6A2-4A5B-B32F-1C529A4B5274Q37123246-6E44BD1D-3F6A-4AC6-B1D2-9FEF3A944D13Q37384107-68DD4C69-01B2-4F2F-B52D-B5D2558C064AQ37547321-68ADD6F5-F08C-434F-A8BC-5143EEBA10C2Q37562093-A7217EAF-2F70-40B2-9B2F-7604DA25A9FEQ38090596-27878E83-7B8B-46FD-90A8-1D848E1F9422Q38259278-6F1AF285-16B6-4CB6-B9AD-9BF007E075D0Q38400912-4498885F-FCBA-4292-BF79-F472066F2423Q38440804-8EA1849D-82AC-4FD9-B79B-2E81BBDB33B0Q38705672-0C911F90-E118-40B6-9271-FE49EB8F366BQ38778924-4FAEFB39-B574-4F07-9AF8-E5AAE89CD467Q38855080-07732449-5CF7-42ED-81C1-35E1DF97E2F4Q39333889-71E1509E-D998-4B02-9156-9B8A187C347AQ39333947-994341F3-81BA-422C-A157-202BA8D6EE98Q39381467-21AB58F0-E87D-4ECB-A118-3F3CA618075DQ39410061-E4C1738B-877E-4159-92C9-519BFAC9CEE4Q41936592-521598AB-A74E-4395-A3B1-7CB5411E0179Q42271849-2DC49DE2-4DB6-44ED-AFBF-E72599781BF3Q43573251-204E54D5-2837-4DA3-A84E-620B3C389EDF
P2860
Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of the Epstein-Barr virus ...... s of nasopharyngeal carcinoma.
@en
Role of the Epstein-Barr virus ...... s of nasopharyngeal carcinoma.
@nl
type
label
Role of the Epstein-Barr virus ...... s of nasopharyngeal carcinoma.
@en
Role of the Epstein-Barr virus ...... s of nasopharyngeal carcinoma.
@nl
prefLabel
Role of the Epstein-Barr virus ...... s of nasopharyngeal carcinoma.
@en
Role of the Epstein-Barr virus ...... s of nasopharyngeal carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Role of the Epstein-Barr virus ...... s of nasopharyngeal carcinoma.
@en
P2093
Christopher W Dawson
Lawrence S Young
Mhairi A Morris
P2860
P304
P356
10.2217/FON.09.53
P407
P577
2009-08-01T00:00:00Z